J&J Comprehensive Care Unit Will Disband As Company Consolidates
This article was originally published in The Gray Sheet
Executive Summary
Johnson & Johnson is scuttling the short-lived management group that oversees its stent, diagnostics, vision and diabetes businesses, citing a need to consolidate in the still shaky economy